Principal Financial Group’s Stoke Therapeutics STOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$224K Sell
8,624
-61,256
-88% -$1.85M ﹤0.01% 2093
2026
Q2
$2.29M Buy
69,880
+5,947
+9% +$191K ﹤0.01% 1824
2026
Q1
$2.08M Sell
63,933
-6,349
-9% -$208K ﹤0.01% 1819
2025
Q4
$2.23M Buy
70,282
+25,077
+55% +$754K ﹤0.01% 1822
2025
Q3
$1.06M Buy
+45,205
New +$775K ﹤0.01% 1916
2024
Q2
– Sell
-10,451
Closed -$141K – 2457
2024
Q1
$141K Sell
10,451
-1,586
-13% -$9.6K ﹤0.01% 2233
2023
Q4
$63.3K Sell
12,037
-94
-0.8% -$402 ﹤0.01% 2314
2023
Q3
$47.8K Buy
12,131
+743
+7% +$4.89K ﹤0.01% 2349
2023
Q2
$121K Buy
+11,388
New +$121K ﹤0.01% 2262
2021
Q3
– Sell
-8,365
Closed -$282K – 2620
2021
Q2
$282K Buy
+8,365
New +$296K ﹤0.01% 2381
2020
Q4
– Sell
-6,658
Closed -$223K – 2458
2020
Q3
$223K Buy
+6,658
New +$190K ﹤0.01% 2183

Other funds holding STOK

Principal Financial Group's STOK Position: Q3 2026 in Review

Principal Financial Group reduced its Stoke Therapeutics (STOK) stake by 88% in Q3 2026, selling an estimated $1.85M and leaving 8,624 shares worth $224K. The position accounts for ﹤0.01% of the portfolio, ranked #2093.

Principal Financial Group first reported a position in STOK in Q3 2020 and has held it in 11 quarters since. The position peaked at $2.29M in Q2 2026. 185 funds tracked by Wall St. Rank hold STOK as of Q3 2026.

  • Principal Financial Group held 8,624 shares of Stoke Therapeutics worth $224K as of Q3 2026.
  • Principal Financial Group sold 61,256 Stoke Therapeutics shares in Q3 2026, an estimated $1.85M.
  • Stoke Therapeutics made up ﹤0.01% of Principal Financial Group's portfolio in Q3 2026, its #2093 holding.
  • Principal Financial Group first reported a position in Stoke Therapeutics in Q3 2020 and has held it in 11 quarters since.
  • Principal Financial Group's Stoke Therapeutics position peaked at $2.29M in Q2 2026.
  • 185 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q3 2026.

Based on Principal Financial Group's 13F filing for Q3 2026, filed 2 Nov 2026.